The pachychoroid spectrum disease includes central serous chorioretinopathy, pachychoroid pigment epitheliopathy, pachychoroid neovascularization and polypoidal choroidal vasculopathy. A spectrum of diseases with a pachychoroid-driven process have features of an increase in choroidal thickness and dilated
choroidal vessels in common. The investigation of mechanism and image features may help us to diagnose this kind of disease and give us the right directions to study in future steps.
徐奕爽,苏钰,陈长征. 脉络膜增厚谱系疾病的研究现状与进展[J]. 中华眼视光学与视觉科学杂志, 2018, 20(4): 253-256.
Yishuang Xu,Yu Su,Changzheng Chen. Progress and Research in Pachychoroid Spectrum Disease. Chinese Journal of Optometry Ophthalmology and Visual science, 2018, 20(4): 253-256. DOI: 10.3760/cma.j.issn.1674-845X.2018.04.013
Jia Y, Tan O, Tokayer J, et al. Split-spectrum amplitudedecorrelation angiography with optical coherence tomography.Opt Express, 2012, 20(4): 4710-4725.
Jia Y, Tan O, Tokayer J, et al. Split-spectrum amplitudedecorrelation angiography with optical coherence tomography.Opt Express, 2012, 20(4): 4710-4725.
Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol, 1967, 63(3): Suppl: 1-139c.
[4]
Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol, 1967, 63(3): Suppl: 1-139c.
[5]
Bandello F, Incorvaia C, Parmeggiani F, et al. Idiopathic multiple serous detachments of the retinal pigment epithelium followed by bilateral central serous chorioretinopathy: a
case report. Ophthalmologica, 2000, 214(5): 362-367. DOI:10.1159/000027522.
[5]
Bandello F, Incorvaia C, Parmeggiani F, et al. Idiopathic multiple serous detachments of the retinal pigment epithelium followed by bilateral central serous chorioretinopathy: a
case report. Ophthalmologica, 2000, 214(5): 362-367. DOI:10.1159/000027522.
[6]
Gómez-Ulla F, Vázquez JM, Rodríguez-Cid MJ, et al. Central serous chorioretinopathy following pigment epithelium detachment: fluorescein and indocyanine green angiography
[6]
Gómez-Ulla F, Vázquez JM, Rodríguez-Cid MJ, et al. Central serous chorioretinopathy following pigment epithelium detachment: fluorescein and indocyanine green angiography
Yan YN, Wang YX, Xu L, et al. Fundus tessellation:Prevalence and associated factors: The Beijing Eye Study 2011.Ophthalmology, 2015, 122(9): 1873-1880. DOI: 10.1016/
Yan YN, Wang YX, Xu L, et al. Fundus tessellation:Prevalence and associated factors: The Beijing Eye Study 2011.Ophthalmology, 2015, 122(9): 1873-1880. DOI: 10.1016/
j.ophtha.2015.05.031.
j.ophtha.2015.05.031.
[8]
Gallego-Pinazo R, Dolz-Marco R, Gómez-Ulla F, et al.Pachychoroid diseases of the macula. Med Hypothesis Discov Innov Ophthalmol, 2014, 3(4): 111-115.
[9]
Dansingani KK, Balaratnasingam C, Naysan J, et al. En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina, 2016, 36(3): 499-516.DOI: 10.1097/IAE.0000000000000742.
[8]
Gallego-Pinazo R, Dolz-Marco R, Gómez-Ulla F, et al.Pachychoroid diseases of the macula. Med Hypothesis Discov Innov Ophthalmol, 2014, 3(4): 111-115.
[9]
Dansingani KK, Balaratnasingam C, Naysan J, et al. En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina, 2016, 36(3): 499-516.DOI: 10.1097/IAE.0000000000000742.
[10]
Fung AT, Yannuzzi LA, Freund KB. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related
Fung AT, Yannuzzi LA, Freund KB. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related
Gergely R, Kovacs I, Schneider M, et al. Mineralocorticoid receptor antagonist treatment in bilateral chronic central serous chorioretinopathy: A comparative study of exudative and
Nicholson B, Noble J, Forooghian F, et al. Central serous chorioretinopathy: update on pathophysiology and treatment.Surv Ophthalmol, 2013, 58(2): 103-126. DOI: 10.1016/
[11]
Gergely R, Kovacs I, Schneider M, et al. Mineralocorticoid receptor antagonist treatment in bilateral chronic central serous chorioretinopathy: A comparative study of exudative and
Nicholson B, Noble J, Forooghian F, et al. Central serous chorioretinopathy: update on pathophysiology and treatment.Surv Ophthalmol, 2013, 58(2): 103-126. DOI: 10.1016/
j.survophthal.2012.07.004.
j.survophthal.2012.07.004.
[13]
Spaide RF, Goldbaum M, Wong DW, et al. Serous detachment of the retina. Retina, 2003, 23(6): 820-846; quiz 895-896.
[13]
Spaide RF, Goldbaum M, Wong DW, et al. Serous detachment of the retina. Retina, 2003, 23(6): 820-846; quiz 895-896.
[14]
Tittl M, Polska E, Kircher K, et al. Topical fundus pulsation measurement in patients with active central serous chorioretinopathy. Arch Ophthalmol, 2003, 121(7): 975-978.
DOI: 10.1001/archopht.121.7.975.
[15]
Teussink MM, Breukink MB, van Grinsven MJ, et al. OCTangiography compared to fluorescein and indocyanine green angiography in chronic central serous chorioretinopathy. Invest Ophthalmol Vis Sci, 2015, 56(9): 5229-5237. DOI: 10.1167/iovs.15-17140.
[16]
Quaranta-El MM, El MA, Eandi CM. Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography. Am J Ophthalmol, 2015, 160(3): 581-587.e1. DOI:10.1016/j.ajo.2015.06.016.
[17]
Bonini FMA, de Carlo TE, Ferrara D, et al. Association of choroidal neovascularization and central serous chorioretinopathy with optical coherence tomography angiography. JAMA Ophthalmol, 2015, 133(8): 899-906. DOI:10.1001/jamaophthalmol.2015.1320.
[14]
Tittl M, Polska E, Kircher K, et al. Topical fundus pulsation measurement in patients with active central serous chorioretinopathy. Arch Ophthalmol, 2003, 121(7): 975-978.
DOI: 10.1001/archopht.121.7.975.
[15]
Teussink MM, Breukink MB, van Grinsven MJ, et al. OCTangiography compared to fluorescein and indocyanine green angiography in chronic central serous chorioretinopathy. Invest Ophthalmol Vis Sci, 2015, 56(9): 5229-5237. DOI: 10.1167/iovs.15-17140.
[16]
Quaranta-El MM, El MA, Eandi CM. Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography. Am J Ophthalmol, 2015, 160(3): 581-587.e1. DOI:10.1016/j.ajo.2015.06.016.
[17]
Bonini FMA, de Carlo TE, Ferrara D, et al. Association of choroidal neovascularization and central serous chorioretinopathy with optical coherence tomography angiography. JAMA Ophthalmol, 2015, 133(8): 899-906. DOI:10.1001/jamaophthalmol.2015.1320.
[18]
Shulman S, Goldenberg D, Schwartz R, et al. Oral rifampin treatment for longstanding chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol, 2016,
25
4(1): 15-22. DOI: 10.1007/s00417-015-2989-z.
[19]
Gramajo AL, Marquez GE, Torres VE, et al. Therapeutic benefit of melatonin in refractory central serous chorioretinopathy. Eye (Lond), 2015, 29(8): 1036-1045. DOI: 10.1038/eye.2015.104.
[20]
Pang CE, Freund KB. Pachychoroid neovasculopathy. Retina, 2015, 35(1): 1-9. DOI: 10.1097/IAE.0000000000000331.
[18]
Shulman S, Goldenberg D, Schwartz R, et al. Oral rifampin treatment for longstanding chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol, 2016,
25
4(1): 15-22. DOI: 10.1007/s00417-015-2989-z.
[19]
Gramajo AL, Marquez GE, Torres VE, et al. Therapeutic benefit of melatonin in refractory central serous chorioretinopathy. Eye (Lond), 2015, 29(8): 1036-1045. DOI: 10.1038/eye.2015.104.
[20]
Pang CE, Freund KB. Pachychoroid neovasculopathy. Retina, 2015, 35(1): 1-9. DOI: 10.1097/IAE.0000000000000331.
[21]
Dansingani KK, Balaratnasingam C, Klufas MA, et al. Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum
disease. Am J Ophthalmol, 2015, 160(6): 1243-1254.e2. DOI:10.1016/j.ajo.2015.08.028.
[22]
Azar G, Wolff B, Mauget-Faÿsse M, et al. Pachychoroid neovasculopathy: aspect on optical coherence tomography angiography. Acta Ophthalmol, 2017, 95(4): 421-427. DOI:
[21]
Dansingani KK, Balaratnasingam C, Klufas MA, et al. Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum
disease. Am J Ophthalmol, 2015, 160(6): 1243-1254.e2. DOI:10.1016/j.ajo.2015.08.028.
[22]
Azar G, Wolff B, Mauget-Faÿsse M, et al. Pachychoroid neovasculopathy: aspect on optical coherence tomography angiography. Acta Ophthalmol, 2017, 95(4): 421-427. DOI:
10
1111/aos.13221.
[23]
Miyake M, Ooto S, Yamashiro K, et al. Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep,2015, 5: 16204. DOI: 10.1038/srep16204.
[24]
Gupta MP, Rusu I, Seidman C, et al. Pachychoroid neovasculopathy in extramacular choroidal neovascularization.Clin Ophthalmol, 2016, 10: 1275-1282. DOI: 10.2147/OPTH.
10
1111/aos.13221.
[23]
Miyake M, Ooto S, Yamashiro K, et al. Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep,2015, 5: 16204. DOI: 10.1038/srep16204.
[24]
Gupta MP, Rusu I, Seidman C, et al. Pachychoroid neovasculopathy in extramacular choroidal neovascularization.Clin Ophthalmol, 2016, 10: 1275-1282. DOI: 10.2147/OPTH.
S105080.
S105080.
[25]
Tomiyasu T, Nozaki M, Yoshida M, et al. Characteristics of Polypoidal Choroidal Vasculopathy Evaluated by Optical Coherence Tomography Angiography. Invest Ophthalmol Vis
Khan S, Engelbert M, Imamura Y, et al. Polypoidal choroidal vasculopathy: simultaneous indocyanine green angiography and eye-tracked spectral domain optical coherence tomography findings. Retina, 2012, 32(6): 1057-1068. DOI: 10.1097/IAE.0b013e31823beb14.
[27]
Kokame GT. Polypoidal choroidal vasculopathy-a type I polypoidal subretinal neovasculopathy. Open Ophthalmol J,2013, 7: 82-84. DOI: 10.2174/1874364101307010082.
[28]
Nakashizuka H, Mitsumata M, Okisaka S, et al. Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci, 2008, 49(11): 4729-4737. DOI: 10.1167/
[25]
Tomiyasu T, Nozaki M, Yoshida M, et al. Characteristics of Polypoidal Choroidal Vasculopathy Evaluated by Optical Coherence Tomography Angiography. Invest Ophthalmol Vis
Khan S, Engelbert M, Imamura Y, et al. Polypoidal choroidal vasculopathy: simultaneous indocyanine green angiography and eye-tracked spectral domain optical coherence tomography findings. Retina, 2012, 32(6): 1057-1068. DOI: 10.1097/IAE.0b013e31823beb14.
[27]
Kokame GT. Polypoidal choroidal vasculopathy-a type I polypoidal subretinal neovasculopathy. Open Ophthalmol J,2013, 7: 82-84. DOI: 10.2174/1874364101307010082.
[28]
Nakashizuka H, Mitsumata M, Okisaka S, et al. Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci, 2008, 49(11): 4729-4737. DOI: 10.1167/
iovs.08-2134.
[29]
van Velthoven ME, Verbraak FD, Garcia PM, et al. Evaluation of central serous retinopathy with en face optical coherence tomography. Br J Ophthalmol, 2005, 89(11): 1483-1488. DOI:10.1136/bjo.2005.073056.
iovs.08-2134.
[29]
van Velthoven ME, Verbraak FD, Garcia PM, et al. Evaluation of central serous retinopathy with en face optical coherence tomography. Br J Ophthalmol, 2005, 89(11): 1483-1488. DOI:10.1136/bjo.2005.073056.
[30]
Kitaya N, Nagaoka T, Hikichi T, et al. Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol, 2003, 87(6): 709-712.
[30]
Kitaya N, Nagaoka T, Hikichi T, et al. Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol, 2003, 87(6): 709-712.
浙公网安备 33030202001892号